Akamatsu H, Nishijima S, Akamatsu M, Kurokawa I, Sasaki H, Asada Y
Department of Dormatology, Kansai Medical University, Osaka, Japan.
J Int Med Res. 1996 Jan-Feb;24(1):27-32. doi: 10.1177/030006059602400104.
The effect of roxithromycin (ROM), a new oral semi-synthetic macrolide, on the generation of reactive oxygen species (ROS), using human neutrophils and a cell-free, xanthine-xanthine oxidase system was examined. The species investigated were the superoxide radical anion (O2-), hydrogen peroxide (H2O2), and the hydroxyl radical (OH.). ROM effectively inhibited the generation of O2-, H2O2 and OH. by human neutrophils. On the other hand, the drug did not markedly affect the ROS levels generated in the xanthine-xanthine oxidase system. The present study indicates that ROM may exert an anti-inflammatory action by inhibiting neutrophil oxygen radical generation at the sites of inflammation.
使用人中性粒细胞和无细胞的黄嘌呤-黄嘌呤氧化酶系统,研究了新型口服半合成大环内酯类药物罗红霉素(ROM)对活性氧(ROS)生成的影响。所研究的物质包括超氧阴离子自由基(O2-)、过氧化氢(H2O2)和羟基自由基(OH·)。ROM有效抑制了人中性粒细胞产生O2-、H2O2和OH·。另一方面,该药物对黄嘌呤-黄嘌呤氧化酶系统中产生的ROS水平没有明显影响。本研究表明,ROM可能通过抑制炎症部位的中性粒细胞氧自由基生成而发挥抗炎作用。